Topical Treatment

Lapins J, Jarstrand C, Emtestam L. Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol 1999; Jan, 140(1):90–5PubMedCrossRefGoogle Scholar

Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol 1983; 22:325–328PubMedGoogle Scholar

Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 1998; 39:971–974PubMedCrossRefGoogle Scholar

Akhavan A, Bershad S. Topical acne drugs: review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol 2003; 4:473–492PubMedCrossRefGoogle Scholar

Krautheim A, Gollnick H. Transdermal penetration of topical drugs used in the treatment of acne. Clin Pharmacokinet 2003; 42:1287–1304PubMedCrossRefGoogle Scholar

Parry MF, Rha CK. Pseudomembranous colitis caused by topical clindamycin phosphate. Arch Dermatol 1986; 122:583–584PubMedCrossRefGoogle Scholar

Milstone EB, McDonald AJ, Scholhamer CF Jr. Pseudomembranous colitis after topical application of clindamycin. Arch Dermatol 1981; 117:154–155PubMedCrossRefGoogle Scholar

Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, Shalita A, Thiboutot D. Management of acne. Topical retinoids. J Am Acad Dermatol 2003; 49[Suppl 1]:S5–S11Google Scholar

Yu CC, Cook MG. Hidradenitis suppurativa: a disease of follicular epithelium rather than apocrine glands. Br J Dermatol 1990; 122:763–769PubMedCrossRefGoogle Scholar

Attanoos R, Appleton MAC, Douglas-Jones AG. The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol 1995; 133:254–258PubMedCrossRefGoogle Scholar

Boer J, Weltevreden EF. Hidradenitis suppurativa or acne inversa: a clinicopathological study of early lesions. Br J Dermatol 1996; 135:721–725PubMedCrossRefGoogle Scholar

Boer J, Dijkstra AT, Baar TJM, Meer JB van der. Hidradenitis suppurativa (acne inversa): Lokale behandeling met resorcine. Ned Tijdschr Derm Venereol 2001; 11:348–349Google Scholar

Boer J, Bos WH, Meer JB van der. Hidradenitis suppurativa (acne inversa): behandeling met deroofing en resorcine [English abstract]. Ned Tijdschr Derm Venereol 2004; 14:274–278Google Scholar

Braun Falco O, Plewig G, Wolff HH, Burgdorf WHC. Diseases of the sebaceous Glands. In: Braun Falco O, Plewig G, Wolff HH, Burgdorf WHC (eds) Dermatology, 4th revised edn. Springer, Berlin Heidelberg New York, 1996; pp 1051–1082Google Scholar

Webster GF. Acne vulgaris. Br Med J 2002; 325:475–479CrossRefGoogle Scholar

Stienstra P. Hidradenitis suppurativa. In: Jansen LH (ed) Huid en geslachtsziekten. Scheltema en Holkema, Utrecht, 1975; pp 121–125Google Scholar

Polano MK. Topical therapeutics. Churchill Livingstone, Edinburgh, 1984Google Scholar

Groot de AC. Dermatological drugs, topical agents and cosmetics. In: Dukes MNG, Aronson JK (eds) Meyler’s side effects of drugs, 14th edn. Elsevier, Amsterdam, 2000; p 473Google Scholar

Degreef H, Hulsebos HJ, Mariën KJC, Schroeff JG van der. Behandelingsprincipes. In: Vloten WA, van, Degreef HJ, Stolz E, Vermeer BJ, Willemze R (eds) Dermatologie en Venereologie, 3rd edn. Elsevier, Amsterdam, 2000.Google Scholar

Mills OH, Kligman AM. Assay of comedolytic activity in acne patients. Acta Dermatovenereol 1982; 63:68–71Google Scholar

Mills OH, Kligman AM. Drugs that are ineffective in the treatment of acne vulgaris. Br J Dermatol 1983; 108:371–374PubMedCrossRefGoogle Scholar

Wüthrich B, Zabrodsky S, Storck H. Perkutane Vergiftungen durch Resorcin, Salicylsäure und weisse Präcipitatsalbe. Pharmaceutica Acta Helvetiae 1970; 45:453–460PubMedGoogle Scholar

Häckh G, Schwarzmüller E. Codex dermatologischer Wirkstoffe. In: Niedner R, Ziegenmeyer J (eds) Dermatika. Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1992; pp 447–448Google Scholar

Werth von der JM, Williams HC. The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2000; 14:389–392PubMedCrossRefGoogle Scholar

Cunliffe WJ. Looking back to the future — acne. Dermatology 2002; 204:167–172PubMedCrossRefGoogle Scholar

Cassano N, Alessandrini G, Mastrolonardo M, Vena GA. Peeling agents: toxicological and allergological aspects. J Eur Acad Dermatol Venereol 1999; 13:14–23PubMedGoogle Scholar

Bontemps H, Mallaret M, Besson G, Bochaton H, Carpentier F. Confusion after topical use of resorcinol. Arch Dermatol 1995; 131:112PubMedCrossRefGoogle Scholar

Cunningham AA. Resorcine poisoning. Arch Dis Child 1956; 31:173–176PubMedCrossRefGoogle Scholar

Plas M van der, Bos WH. Chirurgische behandeling (epitheliale adnexcysten) door de dermatoloog [English abstract]. Ned Tijdschr Derm Venereol 1994; 4:101–103Google Scholar

Breathnach AS. Azelaic acid: potential as a general antitumoural agent. Med Hypotheses 1999; 52:221–226PubMedCrossRefGoogle Scholar

Brasch J, Christophers E. Azelaic acid has antimycotic properties in vitro. Dermatology 1993; 186:55–58PubMedCrossRefGoogle Scholar

Detmar M, Mayer-da-Silva A, Stadler R, Orfanos CE. Effects of azelaic acid on proliferation and ultrastructure of mouse keratinocytes in vitro. J Invest Dermatol 1989; 93:70–74PubMedCrossRefGoogle Scholar

Topert M, Rach P, Siegmund F. Pharmacology and toxicology of azelaic acid. Acta Dermatol Venereol Suppl (Stockh) 1989; 143:14–19Google Scholar

Passi S, Picardo M, Mingrone G, Breathnach AS, Nazzaro-Porro M. Azelaic acid — biochemistry and metabolism. Acta Dermatol Venereol Suppl (Stockh) 1989; 143:8–13Google Scholar

Galhaup I. Azelaic acid: mode of action at cellular and subcellular levels. Acta Dermatol Venereol Suppl (Stockh) 1989; 143:75–82Google Scholar

Bojar RA, Holland KT, Leeming JP, Cunliffe WJ. Azelaic acid: its uptake and mode of action in Staphylococcus epidermidis NCTC 11047. J Appl Bacteriol 1988; 64:497–504PubMedGoogle Scholar

Wilkinson JD. Fusidic acid in dermatology. Br J Dermatol 1998;139[Suppl] 53:37–40PubMedCrossRefGoogle Scholar

Levine RM, Rasmussen JE. Intralesional corticosteroids in the treatment of nodulocystic acne. Arch Dermatol 1983; 119:480–481PubMedCrossRefGoogle Scholar

Jansen T, Romiti R, Plewig G, Altmeyer P. Disfiguring draining sinus tracts in a female acne patient. Pediatr Dermatol 2000; 17:123–125PubMedCrossRefGoogle Scholar